Healthcare - Biotechnology - NASDAQ - US
$ 0.6704
5.46 %
$ 13.1 M
Market Cap
-0.25
P/E
BALANCE SHEET
2.71 M
ASSETS
3.36 M
LIABILITIES
-323 K
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Ensysce Biosciences, Inc.
| Current Assets | 2.29 M |
| Cash & Short-Term Investments | 1.12 M |
| Receivables | 97.6 K |
| Other Current Assets | 1.07 M |
| Non-Current Assets | 419 K |
| Long-Term Investments | 0 |
| PP&E | 0 |
| Other Non-Current Assets | 419 K |
| Current Liabilities | 3.33 M |
| Accounts Payable | 1.94 M |
| Short-Term Debt | 855 K |
| Other Current Liabilities | 542 K |
| Non-Current Liabilities | 26.4 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 26.4 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 1.1 | 3.1 | 12.3 | 0.2 | 1.1 | 1.7 | 2.1 |
| Short Term Investments | 0 | 0 | 0 | 0 | 195.3 | 202.9 | 200.1 |
| Receivables | 97.6 K | 0.3 | 0.4 | 0 | 0 | 0.2 | 0 |
| Inventory | 0 | (0.3) | (0.4) | 0 | 1 | 0 | 0 |
| Other Current Assets | 1.1 | 1.9 | 3.0 | 0.2 | 0.1 | 87.1 K | 0.2 |
| Total Current Assets | 2.3 | 5.3 | 15.7 | 0.3 | 1.2 | 1.9 | 2.3 |
| PP&E | 0 | 27.2 K | 24 721.0 | 151 | 351 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 195.3 | 202.9 | 200.1 |
| Other Long Term Assets | 0.4 | 0.6 | (24 720.2) | 3.78 K | 351 | 1 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total Assets | 2.7 | 5.9 | 16.4 | 0.4 | 196.5 | 204.8 | 202.4 |
| LIABILITIES | |||||||
| Accounts Payable | 1.9 | 2.9 | 0.3 | 1.7 | 0.5 | 0 | 0 |
| Short Term Debt | 0.9 | 4.3 | 12.8 | 4.3 | 0 | 0 | 0 |
| Other Current Liabilities | 0.5 | 2.2 | 3.4 | 0.9 | 2.1 | 0.4 | 0.2 |
| Total Current Liabilities | 3.3 | 9.5 | 16.5 | 7.0 | 2.8 | 0.4 | 0.2 |
| Long Term Debt | 0 | 0.1 | 4.4 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | (7.6) | 1.76 K | 0 |
| Other Liabilities | 26.4 K | 0.3 | 3.7 | 0 | 7.6 | 0 | 0 |
| Total Liabilities | 3.4 | 9.9 | 24.6 | 7.0 | 10.3 | 7.4 | 7.2 |
| EQUITY | |||||||
| Common Stock | 315 | 642 | 2.46 K | 1.58 K | 181.2 | 604 | 673 |
| Retained Earnings | (121.6) | (110.9) | (85.8) | (56.0) | 2.5 | 2.1 | 31.2 K |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | 604 | 673 |
| Total Equity | (0.7) | (4.3) | (8.4) | (6.7) | 186.2 | 197.4 | 195.3 |
| Total Liabilities and Equity | 2.7 | 5.9 | 16.4 | 0.4 | 196.5 | 204.8 | 202.4 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 2.3 | 0.2 | 84 K | 65.7 K | 98.3 K | 0.1 | 0.1 |